Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services

Junling Wang1, Yanru Qiao2, Christina A Spivey3

  • 1Department of Clinical Pharmacy, The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Room 221, Memphis, TN 38163.

Abstract

Insights

Proposed Medicare medication therapy management (MTM) eligibility criteria did not eliminate racial and ethnic disparities. Hispanics were less likely to qualify, indicating a need for new MTM eligibility criteria.

Area of Science:

  • Health Services Research
  • Health Disparities
  • Pharmaceutical Policy

Background:

  • Racial and ethnic minorities historically face barriers to Medicare Medication Therapy Management (MTM) eligibility.
  • The Centers for Medicare & Medicaid Services (CMS) proposed revised MTM eligibility criteria for 2015 to address these disparities.
  • These proposed reforms were ultimately rescinded by CMS.

Purpose of the Study:

  • To evaluate whether the proposed 2015 Medicare MTM eligibility criteria would reduce or eliminate disparities for non-Hispanic Blacks and Hispanics compared to non-Hispanic Whites.
  • To analyze the likelihood of meeting the proposed criteria across different racial and ethnic groups.

Main Methods:

  • Retrospective analysis of 2010-2011 Medical Expenditure Panel Survey data.
  • Inclusion of weighted samples representing 37,185,896 Whites, 4,665,644 Blacks, and 3,532,882 Hispanics.
  • Chi-square tests and multivariate logistic regression were used to assess disparities in MTM eligibility and control for demographic and health factors.

Main Results:

  • While 58.82% of Whites met the criteria, only 57.09% of Blacks (P=0.20) and 48.97% of Hispanics (P<0.0001) were eligible.
  • Multivariate analysis showed significantly lower odds of MTM eligibility for Hispanics (OR=0.53) and Blacks (OR=0.74) compared to Whites.
  • The proposed criteria did not achieve parity in MTM eligibility across racial and ethnic groups.

Conclusions:

  • The proposed 2015 Medicare MTM eligibility criteria failed to eliminate existing racial and ethnic disparities.
  • Significant disparities in MTM eligibility persist, particularly for Hispanic individuals.
  • Development of alternative MTM eligibility criteria is necessary to ensure equitable access to medication therapy management services.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
360
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
465
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
306
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
993
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.6K